GLP-1 receptor agonists offer unique benefits, including weight loss and cardiovascular protection, which are not provided by all diabetes medications
Toxics 12 , 294 (2024)
A Brave New World: Therapeutic Area Deep Dives on Obesity This blog is part of a new series exploring a range of topics in the obesity market, including: market size and scope, impact of payer controls, activity in non-traditional channels, patient behavior, GLP-1 impact, HCP responses, the policy landscape, pharmacy economics, and the outlook for the future of GLP-1
These hormonal effects can be beneficial for managing type 2 diabetes and promoting weight loss
But since compounded forms of the drug are not FDA-approved, those who make, prescribe, or use them also should have an increased level of responsibility or awareness, she said